Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20101
20171
20181
20192
20205
20212
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Completed8
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.3
AstraZeneca2
National Cancer Institute (NCI)2
Sunnybrook Health Sciences Centre2
AbbVie1
Alliance for Clinical Trials in Oncology1
Astellas Pharma Global Development, Inc.1
British Columbia Cancer Agency1
Fusion Pharmaceuticals Inc.1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms22
Endometrial Neoplasms7
Melanoma7
Carcinoma, Non-Small-Cell Lung6
Ovarian Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Stomach Neoplasms6
Carcinoma, Renal Cell5
Colorectal Neoplasms5
Triple Negative Breast Neoplasms5

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.